Request for EOI: Assessing the safety and effectiveness of current and future SARS-CoV-2 vaccines deployed in Canada

The Canadian Vaccine Surveillance Reference Group (VSRG), in partnership with the COVID-19 Immunity Task Force (CITF), and with the support of the Public Health Agency of Canada (PHAC), is inviting the Canadian research community to apply for funding to assess the safety and effectiveness of current and future SARS-CoV-2 vaccines deployed in Canada.

Two COVID-19 vaccines already approved by Canadian regulators are now in use. More are expected to be introduced in the months ahead. In this unprecedented situation with emergency approvals and rapid roll-out of new vaccines, there are many unanswered questions. The VSRG, drawing on colleagues from the National Advisory Committee on Immunization (NACI), the Canadian Immunization Research Network (CIRN), and the CITF, is prepared to fund research teams that can address major aspects of the safety and effectiveness of COVID-19 vaccines with public health relevance.

This call for proposals consists of a fast-tracked 2-step process that aims to expedite vaccine surveillance related research that has been deemed a public health priority.

For more information and application form, please visit their website.

Expressions of Interest will be processed as they are received until Monday, February 15^th, 2021.

Full applications will be accepted continuously from the time an applicant is invited and will be sent for review upon submission on a rolling basis until March 15^th, 2021.

We invite you to share this call with your colleagues, as applicable.